Latest Park West Asset Management News
Nov 7, 2021
Back to HomeCAMBRIDGE, MA, Parthenon Therapeutics announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures.Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, announced a $65 million Series A financing led by Northpond Ventures, Pfizer Ventures, and Taiho Ventures.Additional investors included Section 32, Breakout Ventures, funds managed by Tekla Capital Management LLC, Creacion Ventures, KdT Ventures, Park West Asset Management LLC, and Alexandria Venture Investments. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
Park West Asset Management Team
1 Team Member
Park West Asset Management has 1 team member, including former Executive Vice President, Marcus King.